Dr. Greg Vigna, national malpractice and mid-urethral sling attorney, states, “Our complaints include the following allegations: Prior to the date the Altis device was implanted into Plaintiff’s body, Coloplast also deliberately and/or carelessly failed to warn Plaintiff and her health care providers of the device’s higher risks of chronic groin pain and risk of dyspareunia [...]
“Delayed diagnoses and treatment of the complications that are known to be caused by mid-urethral slings including mini-slings leads to disabling pain syndromes that can be mitigated with timely diagnosis and treatment before the fibrosis of the mesh device occurs" states Greg Vigna, MD, JD, national malpractice attorney. We are investigating sources of liability as described [...]
“We allege that our client has been seriously injured from the negligent selection of the Altis mini-sling and the negligent failure to timely diagnose and treat the known complications of this device” states Greg Vigna, MD, JD, national malpractice attorney. Dr. Greg Vigna, mid-urethral sling attorney states, “Dr. Elizabeth Tourville, is alleged to have failed to [...]
“A pressure ulcer should be closed surgically if it does not respond to wound care and there is no other contradiction to the surgical procedures. Exceptions may include the elderly or patients with a fatal illness, for whom palliative, local wound care is more appropriate” states Lisa J. Gould, MD, PhD, Plastic Surgeon, Chairperson, WHS [...]
“Chronic pain diagnoses increased risk of midurethral sling revision/removal; pelvic pain and numbers of diagnoses increased this risk,” states Dr. Nicholas F. Rockefeller, M.D. What else did Dr. Rockefeller report in “Midurethral Sling Removal or Revision in Women with Chronic Pain,” published in Female Pelvic Medicine & Reconstructive Surgery. Volume 28, Number 5, May 2022? [...]
“Our client has been seriously injured from the selection of the Altis mini-sling, and the failure to timely diagnose and treat the known complications of this unreasonably dangerous device” states Greg Vigna, MD, JD, national malpractice attorney. Dr. Greg Vigna, mid-urethral sling attorney says, “The implanting physician named in this lawsuit chose to implant the Altis [...]
“There are some weakness to this data … 564 were analyzed … at year one, data for 427 subjects was available … for attrition rate of 24.3% ... After 3 years, 307 were available for evaluation (46% attrition rate)” says Dr. Frank Van der Aa, Department of Urology. University Hospitals Leuven, Belgium. What else did [...]
“Neither diabetes nor other treatable comorbidities were significantly associated with major complications if the treatment of these factors is included in a multidisciplinary approach" says Dr. Dirk J Schaefer, Department of Plastic Surgery, University Hospital of Basel, Switzerland. What did Dr. Dirk J Schaefer report in “Risk Factors of Major Complications After Flap Surgery in [...]
“The weakness of the Altis 522 study include … high attrition rate (at 36-months, the attrition rate for the Altis arm was 23.9%, whereas the attrition rate for the Comparator arm was 40.9%)" according to the FDA Home 522 Postmarket Surveillance Studies Database. Greg Vigna, MD, JD, national mid-urethral sling attorney, states “Unfortunately the FDA [...]
“The most common foci in hospitalized patients are infections of the lower respiratory tract, followed by intra-abdominal, bloodstream, intravascular line infections, and urinary tract infections," says Dr. Michael S. Niederman, Critical Care, Cornell Medical Center. What did Dr. Niederman say in the study, “Initial Antimicrobial Management of Sepsis” in Critical Care, (2021) 25:307? “Rhee and [...]